After a period where vaccine development had fallen away, suddenly it is back in the limelight. Investment has The post Does the pandemic mark a turning...
The World Health Organization (WHO) announced the opening of a global biomanufacturing hub located in South Korea to The post WHO announces international...
The US drug manufacturing site most arguably in need of an upgrade is now getting one. Emergent BioSolutions had already scheduled some maintenance at...
Sponsored content brought to you by By Sebastian Almeida, Director, CMC, Akron Biotech; Lloyd Jeffs, Director, Clinical Manufacturing Solutions, Precision...
Citing its commitment to equitable vaccine access, Moderna pledged early on that it wouldn’t enforce its Covid-related IP rights while the pandemic is...
BioNTech is developing a turnkey solution to enable mRNA-based vaccine production in modular and scalable sites. The company plans to establish mRNA manufacturing...
What do you get when you combine 12 shipping containers and some of the most innovative science surrounding vaccines there is? A futuristic way to make...
What do you get when you combine 12 shipping containers and some of the most innovative science surrounding vaccines there is? A futuristic way to make...
We must work together to end the pandemic, navigate monetary tightening and shift focus to fiscal sustainability.
The European Union and the Gates Foundation will invest over 100 million euros ($113.4 million) during the next five years to help set up an African...
Reminiscent of the 2009 H1N1 Influenza pandemic, the COVID-19 pandemic is perpetuating the stark reality of vaccine insecurity in Africa. Less than 1 percent...
According to the latest Global Economic Prospects Report, by the end of 2022, the world will be, at best, half-recovered. Perhaps the single most important...
The global roll-out of COVID-19 vaccines to date is neither inclusive nor adequately planned: Many countries are already administering boosters while the rest of the world...
CORBEVAX is anticipated to significantly expand vaccine access to people in low- and middle-income countries.
Robust and reliable vaccine capacity in Africa is a global public good, deserving of global support.
Supply chain issues, emergency science, social distancing requirements and a lot more free time offered both challenges and opportunities for research scientists.
It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina The post 2021: the year mRNA therapeutics came...
Casedemic: The Hideous Scandal Of The Irredeemably Flawed PCR Test Authored by Ian McNulty via The Brownstone Institute, Investigating the cause of a disease is like...
The pandemic has prompted improvements in mRNA platforms, continuous processing, formulation methods, and logistics that could benefit the vaccine field. The post COVID-19 Shakes Up Vaccine...
Pfizer Inc (NYSE: PFE) has announced that the U.S Food and Drug Administration (FDA) has approved its COVID-19 vaccine for children aged 5-11. The Centre for...
Moderna Shares Crater On Huge Revenue Miss, Massive Guidance Cut Moderna has just reported its Q3 earnings Thursday, revealing a massive miss on Wall Street's revenue...
COVID-19: Moderna Gets Its Miracle Authored by Whitney Webb via Unlimited Hangout, COVID-19 erased the regulatory and trial-related hurdles that Moderna could never surmount before. Yet,...
By Kristalina Georgieva G20 should lead in sharing vaccine doses, helping developing countries financially, and committing to reaching net-zero carbon emissions by mid-century. When G20 leaders...
The US White House has informed governors to prepare for vaccination of children from five years from next month in anticipation of approval of Pfizer Inc....
Shares of Novavax Inc. fell 16 percent after a report from Politico said the company faces significant hurdles in proving it can manufacture the experimental Covid-19...
Production problems at a Novavax facility in Maryland have led to delays in the Covax vaccine sharing program. Now, a shortage of 1 billion doses is...
Viral vectors are modified viruses that trigger an immune response without causing infection. The vector that’s used in several COVID-19 vaccines was created decades ago by...
I am neutral on Emergent BioSolutions Inc. (EBS), as its cheap valuation is largely offset by weak performance in its business, and lack of catalysts for...
Biden Hosts First Quad Summit At White House As 'Counter-China' Allies Cement 'Unofficial' Alliance Amid regional concerns of China's growing power in the Indo-Pacific, President Biden...
On Thursday, Morderna Inc. (NASDAQ:MRNA) CEO told the Swiss newspaper Neue Zuercher Zeitung the coronavirus pandemic could be over in a year. Zeitung thinks increased vaccine...